UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 161 filers reported holding UNIQURE NV in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,223,870 | -41.4% | 182,395 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $2,090,247 | -40.0% | 182,395 | +5.5% | 0.00% | -33.3% |
| Q1 2023 | $3,481,400 | +51.9% | 172,860 | +71.0% | 0.01% | +50.0% |
| Q4 2022 | $2,291,846 | +18.1% | 101,096 | -2.3% | 0.00% | 0.0% |
| Q3 2022 | $1,941,000 | +646.5% | 103,488 | +642.4% | 0.00% | – |
| Q2 2022 | $260,000 | -91.2% | 13,940 | -78.6% | 0.00% | -100.0% |
| Q2 2020 | $2,939,000 | -12.6% | 65,210 | -8.0% | 0.00% | -40.0% |
| Q1 2020 | $3,362,000 | -28.7% | 70,864 | +7.6% | 0.01% | +25.0% |
| Q4 2019 | $4,718,000 | +116.8% | 65,829 | +19.1% | 0.00% | +100.0% |
| Q3 2019 | $2,176,000 | -63.6% | 55,254 | -27.8% | 0.00% | -66.7% |
| Q2 2019 | $5,982,000 | +27.0% | 76,548 | -3.0% | 0.01% | +20.0% |
| Q1 2019 | $4,709,000 | +214.4% | 78,945 | +51.9% | 0.01% | +150.0% |
| Q4 2018 | $1,498,000 | -24.2% | 51,986 | -4.3% | 0.00% | 0.0% |
| Q3 2018 | $1,977,000 | +5.3% | 54,332 | +9.4% | 0.00% | 0.0% |
| Q2 2018 | $1,877,000 | – | 49,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
| Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
| Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
| Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
| Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
| P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
| Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
| Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
| Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |